C000958 Selwyn Calendar 2009-10 v3:Layout 1 29/10/2010 14:05 Page 33
Dr Fabian Grabenhorst writes:
PART TWO
Fabian Grabenhorst has been elected to the Trevelyan Research Fellowship from October 2010. He studied Psychology at the University of Bielefeld, Germany, graduating in 2006. From 20062009 he was a graduate student at Corpus Christi College, Oxford, where he completed a DPhil in Experimental Psychology. In 2009 he performed research at the University of California, Berkeley, before taking up a position at the Department of Physiology, Development and Neuroscience at the University of Cambridge. His research focuses on understanding the brain mechanisms involved in reward processing, emotion, and decision-making by combining human functional neuroimaging, neurophysiological and computational neuroscience approaches. He is currently investigating the neural computations underlying economic valuation and choice processes by analyzing the activity of single neurons in different brain systems.
NEW BYE-FELLOW Dr Robert Saenz writes: Roberto Saenz is a postdoctoral research associate in the Department of Applied Mathematics and Theoretical Physics. Roberto obtained his undergraduate degree in Mathematics from the Universidad Autonoma de Ciudad Juarez, Mexico in 2001 and an MS in Mathematics from the University of Texas at El Paso in 2003. Under the supervision of Prof Herbert Hethcote, he obtained a PhD degree in Applied Mathematical and Computational Sciences from the University of Iowa in 2006. Roberto’s overall research goal is the use of mathematics as a tool to understand and solve problems related to infectious diseases. His current research is on the development of mathematical models for the spread of the influenza virus within an infected host. In particular, he is interested in the relative roles of the different mechanisms for infection control (e.g. cell depletion, immune response, spatial effects). Other topics of study pursued by him are the effect of pathogenicity of avian influenza viruses on infection dynamics and the role of antiviral drug regimens in the emergence of drug resistance for HIV.
33